Literature DB >> 6605829

Spontaneous production of interleukin-1 by human alveolar macrophages.

G A Koretzky, J A Elias, S L Kay, M D Rossman, P C Nowell, R P Daniele.   

Abstract

A culture system was developed in which human peripheral blood mononuclear cells depleted of monocytes did not proliferate in response to the lectin mitogen phytohemagglutinin (PHA). The response of these cells to PHA was reconstituted with both autologous and heterologous alveolar macrophages. In addition, a partial restoration of PHA responsiveness was seen when the monocyte-depleted cells (MDC) were cultured with supernatants from purified alveolar macrophages, indicating the presence of Interleukin-1 (IL-1) activity in these supernatants. This is the first evidence suggesting the production of IL-1 by tissue macrophages from normal human subjects. In contrast to previous studies of IL-1 production by blood macrophages, it was found to be unnecessary to stimulate the alveolar macrophages in vitro to generate soluble factor activity. It was also found that alveolar macrophages produced active supernatants after only 2 hr in culture, whereas previous studies have indicated that blood monocytes must be cultured for at least 24 hr before active supernatants are produced. These differences may provide evidence that macrophages within the alveolar spaces are in an activated state.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605829     DOI: 10.1016/0090-1229(83)90047-8

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  10 in total

1.  Effect of interferon on the induction of human monocyte secretion of interleukin-1 activity.

Authors:  R C Newton
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

Review 2.  Roles of interferon produced in physiological conditions. A speculative review.

Authors:  V Bocci
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

3.  Characterization of IL-1 inhibitory factor released from human alveolar macrophages as IL-1 receptor antagonist.

Authors:  M Takeuchi; S Nagai; H Nakada; H Aung; N Satake; H Kaneshima; T Izumi
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

4.  Relationship between ineffective antigen presentation by murine alveolar macrophages and their immunosuppressive function.

Authors:  I N Mbawuike; H B Herscowitz
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

5.  Enhanced interleukin 1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis.

Authors:  A Shore; S Jaglal; E C Keystone
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

6.  Interleukin 1 in Crohn's disease.

Authors:  J Satsangi; R A Wolstencroft; J Cason; C C Ainley; D C Dumonde; R P Thompson
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

7.  Interleukin 1 secretion from human alveolar macrophages in lung disease.

Authors:  E Eden; G M Turino
Journal:  J Clin Immunol       Date:  1986-07       Impact factor: 8.317

8.  Bleomycin-stimulated hamster alveolar macrophages release interleukin-1.

Authors:  A Suwabe; K Takahashi; S Yasui; S Arai; F Sendo
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

9.  Role of activation in alveolar macrophage-mediated suppression of the plaque-forming cell response.

Authors:  I N Mbawuike; H B Herscowitz
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

Review 10.  Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives.

Authors:  Giuseppe Lopalco; Luca Cantarini; Antonio Vitale; Florenzo Iannone; Maria Grazia Anelli; Laura Andreozzi; Giovanni Lapadula; Mauro Galeazzi; Donato Rigante
Journal:  Mediators Inflamm       Date:  2015-02-16       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.